Physician profile
Patrick Robbins
NPI 1255735759
$641.56
in general payments reported to CMS, 2019-2025
11 companies · $87.75 in 2025
The $87.75 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.33 · 2022: $263 · 2023: $114 · 2024: $83.43 · 2025: $87.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $296.36 | 2021-2023 | Rosa |
| Vertex Pharmaceuticals Incorporated | $90.84 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $63.20 | 2024-2025 | Euflexxa |
| Medline Industries Lp | $40.22 | 2021 | |
| Convatec INC. | $36.85 | 2023-2025 | Aquacel Ag Surgical |
| Pacira Pharmaceuticals Incorporated | $33.72 | 2023 | Exparel, Iovera, Zilretta |
| Pacira Therapeutics, INC. | $23.52 | 2021 | |
| Bioventus LLC | $19.25 | 2023 | Exogen Ultrasound Bone Healing System |
| Sanofi-Aventis U.S. LLC | $14.15 | 2023 | |
| Boston Scientific Corporation | $12.25 | 2022 | |
| Smith+Nephew, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.